Nexgard 28.3 mg (Afoxolaner TABLET (CHEWABLE)) 28.3 MG

NEXGARD 28.3 MG chewable tablets contain afoxolaner, a parasiticide for dogs. This medication is designed to protect against fleas and ticks, ensuring your pet's health and comfort. Ideal for pet owners seeking reliable parasite control.

Strength

28.3 MG

Pack Size

1/3/6

Manufacturer / TM Owner

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NEXGARD 28.3 MG is primarily used for the prevention and treatment of flea and tick infestations in dogs. It is a chewable tablet that provides a convenient way to administer afoxolaner, a parasiticide that targets these common pests. Pet owners often use this medication to maintain their dog's health and prevent the discomfort caused by fleas and ticks.

Side Effects

Common effects of NEXGARD 28.3 MG may include reduced flea and tick activity on dogs. Some pets may experience mild gastrointestinal upset or changes in appetite. It is important to monitor your pet for any unusual reactions and consult a veterinarian if concerns arise.

Precautions & Warnings

Handle NEXGARD 28.3 MG tablets with care, ensuring they are stored in a cool, dry place away from children and other pets. Always follow the dosage instructions provided by your veterinarian. Do not use this medication if your dog is allergic to afoxolaner or any of the inactive ingredients.

Avoid Interactions

NEXGARD 28.3 MG may interact with other medications, particularly those metabolized by the liver. It is important to inform your veterinarian about any other medications your dog is taking. Avoid administering this medication with other parasiticides unless directed by a professional.

Frequently Asked Questions

NEXGARD 28.3 MG is used to prevent and treat flea and tick infestations in dogs.

NEXGARD 28.3 MG is a chewable tablet that can be given directly to your dog or crumbled and mixed with food.

Common side effects may include mild gastrointestinal upset or changes in appetite.

Consult your veterinarian before using NEXGARD 28.3 MG with other medications, especially those metabolized by the liver.

Store NEXGARD 28.3 MG in a cool, dry place away from children and other pets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.